The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index; 42 of the 59 sources its claims cite were checked for support.
Reprogramming to recover youthful epigenetic information and restore vision
Open accessAbstract
Ageing is a degenerative process that leads to tissue dysfunction and death. A proposed cause of ageing is the accumulation of epigenetic noise that disrupts gene expression patterns, leading to decreases in tissue function and regenerative capacity 1-3. Changes to DNA methylation patterns over time form the basis of ageing clocks 4, but whether older individuals retain the information needed to restore these patterns-and, if so, whether this could improve tissue function-is not known. Over time, the central nervous system (CNS) loses function and regenerative capacity 5-7. Using the eye as a model CNS tissue, here we show that ectopic expression of Oct4 (also known as Pou5f1), Sox2 and Klf4 genes (OSK) in mouse retinal ganglion cells restores youthful DNA methylation patterns and transcriptomes, promotes axon regeneration after injury, and reverses vision loss in a mouse model of glaucoma and in aged mice. The beneficial effects of OSK-induced reprogramming in axon regeneration and vision require the DNA demethylases TET1 and TET2. These data indicate that mammalian tissues retain a record of youthful epigenetic information-encoded in part by DNA methylation-that can be accessed to improve tissue function and promote regeneration in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
73 Own result · 20 Own method · 16 Partly supported · 12 Own interpretation · 11 Supported · 3 Supported so far · 2 No full text of the sources · 2 No basis given · 1 Not checked yet · accuracy not yet measured
Every source the paper cites for this claim was checked and supports it.
In the paper
“Changes to DNA methylation patterns over time form the basis of ageing clocks4, but whether older individuals retain the information needed to restore these patterns—and, if so, whether this could improve tissue function—is not known.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Supportedcites [4] Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013). source
The Background describes age-related changes in DNA methylation and age predictors based on methylation levels. In “The changing ticking rate of the epigenetic clock,” the paper states that its clock combines 353 CpG methylation measurements that vary with age. This supports the cited clause; the later question about restoring patterns is not attributed to this source. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In mammals, one of the first systems to lose regenerative potential is the CNS5–7.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
What the sources say
- Not checked — no full text of the sourcecites [5] Kennard, M. A. Relation of age to motor impairment in man and in subhuman primates. Arch. Neurol. Psychiatry 44, 377–397 (1940). source
- Not checked — no full text of the sourcecites [6] Goldberg, J. L., Klassen, M. P., Hua, Y. & Barres, B. A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296, 1860–1864 (2002). source
- Partly supportedcites [7] Yun, M. H. Changes in regenerative capacity through lifespan. Int. J. Mol. Sci. 16, 25392–25432 (2015). sourceExperimental — accuracy not yet measured
Section 2.1 (page unavailable) says mammals can regenerate their spinal cords only partially and only during early development, supporting early loss of regenerative potential in part of the CNS. It does not establish that the CNS as a whole is one of the first systems to lose that potential; Section 2.2 also describes adult neurogenesis that declines with age. (LLM, conf=0.82)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Because Tet1 and Tet2, but not Tet3, were upregulated by OSK35,36 (Extended Data Fig. 6a), we tested the effect of knocking down Tet1 or Tet2 (sh-Tet1 or sh-Tet2) using AAV37 in the context of damaged, OSK-treated RGCs (Extended Data Fig. 6b–d).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Regeneration requires DNA demethylation
What the sources say
- Partly supportedcites [35] Koh, K. P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8, 200–213 (2011). sourceExperimental — accuracy not yet measured
The Results section reports that Tet1 and Tet2 expression increased, while Tet3 expression decreased, when mouse fibroblasts were reprogrammed to iPS cells. However, the paper used Oct4, Sox2, Klf4 and c-Myc (OSKM), not OSK alone, so it does not establish the claimed response to OSK. (LLM, conf=0.87)
- Partly supportedcites [36] Gao, Y. et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12, 453–469 (2013). sourceExperimental — accuracy not yet measured
In “Tet1 Can Facilitate Traditional iPSC Induction in a Hydroxylase-Dependent Manner” (page unavailable), the paper reports that Tet1 progressively increased in both OSK and OSKM reprogramming and that Tet3 was repressed in iPSCs. It reports early Tet2 upregulation for OSKM, but does not establish Tet2 upregulation by OSK alone. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the Yamanaka factors, c-Myc is an oncogene that reduces mouse lifespan20 and is not required for the initiation of cellular reprogramming21.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Reset of ageing signatures, not identity
What the sources say
- Supportedcites [21] Rand, T. A. et al. MYC releases early reprogrammed human cells from proliferation pause via retinoblastoma protein inhibition. Cell Rep. 23, 361–375 (2018). source
The Discussion (page unavailable) states that OSK initiates reprogramming in human cells and that MYC does not affect this initial process. The Results (page unavailable) also report that suppressing endogenous MYC did not alter the emergence of early reprogramming markers. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Elevation of IOP was induced unilaterally by injection of polystyrene microbeads (FluoSpheres; Invitrogen, Carlsbad, CA; 15-μm diameter) to the anterior chamber of the right eye of each animal under a surgical microscope, as previously reported40.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Microbead-induced elevated intraocular pressure (IOP)
What the sources say
- Supportedcites [40] Krishnan, A. et al. Overexpression of soluble Fas ligand following adeno-associated virus gene therapy prevents retinal ganglion cell death in chronic and acute murine models of glaucoma. J. Immunol. 197, 4626–4638 (2016). source
The Methods section (‘Induction of elevated IOP’) describes unilateral injection of 15-μm polystyrene microbeads into the anterior chamber to induce elevated IOP. The Results section (‘sFasL prevents loss of RGCs and axons in a microbead-induced model of glaucoma’) reports that this injection elevated IOP compared with saline controls. (LLM, conf=0.95)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“When applying an elastic net model to train a predictor of age, PCs beyond PC1 did not increase the robustness of the age prediction65.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNAm ageing signature
What the sources say
- Supportedcites [65] Levine, M. et al. A rat epigenetic clock recapitulates phenotypic aging and co-localizes with heterochromatin. eLife 9, e59201 (2020). source
The Results section (Age differences in DNAm) says that including PCs beyond PC1 did not improve age prediction. The Statistical analysis section reports that, in 10-fold cross-validation of the elastic-net model, PC1 alone produced the best age predictor. (LLM, conf=0.90)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To our knowledge, this is the first example of vision loss reversal after glaucomatous injury has occurred, with previous attempts focusing on neuroprotection delivered at an early stage to prevent further disease progression41,42 (Supplementary discussion).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Recovery of vision in mice with glaucoma
What the sources say
- Supportedcites [41] Almasieh, M. & Levin, L. A. Neuroprotection in glaucoma: animal models and clinical trials. Ann. Rev. Vis. Sci. 3, 1–30 (2016). source
The citation is attached to the description of previous attempts, not to the citing authors’ claim that their result is the first reversal. Section 1.4 describes neuroprotection as preserving retinal ganglion cells and visual function, while section 7.1 describes glaucoma trials in terms of slowing progression. Those passages support the cited contrast between preventing further loss and reversing loss that has already occurred. (LLM, conf=0.86)
- Partly supportedcites [42] Levin, L. A. et al. Neuroprotection for glaucoma: requirements for clinical translation. Exp. Eye Res. 157, 34–37 (2017). sourceExperimental — accuracy not yet measured
Section 2 (page unavailable) defines glaucoma neuroprotection as slowing functional loss and disease progression rather than reversing it. Section 7 discusses intervening at an early level of retinal ganglion cell injury, but the paper does not establish that previous attempts were delivered at an early stage. The citing authors’ assertion that their result is the first reversal is their own claim, not the part this citation supports. (LLM, conf=0.82)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Day 4-injured RGCs experienced an acceleration of DNAm age, while OSK expression counteracted this effect (Fig. 2d).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK counters injury-induced DNAm ageing
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OSK-mediated recovery of neurite area, as well as both the number and length of axons, were blocked by Tet2 knockdown, but not by mTOR-S6K inhibition (Extended Data Fig. 8j–s).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Axon regeneration in human neurons
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“When delivered singly, Oct4 or Sox2 alone increased RGC survival slightly (Extended Data Fig. 3e), but none of the single factors alone had any effect on regenerative capacity (Fig. 1d).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 35
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“A proposed cause of ageing is the accumulation of epigenetic noise that disrupts gene expression patterns, leading to decreases in tissue function and regenerative capacity1–3.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Not checked — no full text of the sourcecites [1] Sinclair, D. A., Mills, K. & Guarente, L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science 277, 1313–1316 (1997). source
- Not checked — no full text of the sourcecites [2] Imai, S. & Kitano, H. Heterochromatin islands and their dynamic reorganization: a hypothesis for three distinctive features of cellular aging. Exp. Gerontol. 33, 555–570 (1998). source
- Partly supportedcites [3] Oberdoerffer, P. et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907–918 (2008). sourceExperimental — accuracy not yet measured
The Introduction proposes that chromatin alterations and resulting gene-expression changes can drive aging, and the Discussion describes DNA-damage-induced chromatin reorganization as a possible contributor. Our copy does not establish the claimed decreases in tissue function or regenerative capacity; the Discussion says the physiological relevance of age-related expression changes remains debated. The cited passages have section labels but no page numbers. (LLM, conf=0.88)
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Over time, the central nervous system (CNS) loses function and regenerative capacity5–7.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Not checked — no full text of the sourcecites [5] Kennard, M. A. Relation of age to motor impairment in man and in subhuman primates. Arch. Neurol. Psychiatry 44, 377–397 (1940). source
- Not checked — no full text of the sourcecites [6] Goldberg, J. L., Klassen, M. P., Hua, Y. & Barres, B. A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296, 1860–1864 (2002). source
- Supportedcites [7] Yun, M. H. Changes in regenerative capacity through lifespan. Int. J. Mol. Sci. 16, 25392–25432 (2015). source
Section 2.2 identifies the central nervous system among tissues affected by age-related degeneration and dysfunction. It also reports that adult neurogenesis and neural stem cells decline with age, reducing regenerated neurons and causing functional impairment. Page numbers are not provided in the supplied copy. (LLM, conf=0.92)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“During ageing, for reasons that are unclear, these patterns change in ways that can be used to calculate DNA methylation (DNAm) age, a representation of biological age that can predict future health and lifespan4.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Partly supportedcites [4] Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013). sourceExperimental — accuracy not yet measured
The Background and Conclusions (pages not provided) describe age-related methylation changes and a DNAm-age biomarker derived from them. The paper demonstrates prediction of age, but the passages do not establish that DNAm age predicts future health or lifespan; the Conclusions say its role as a marker of aging needs further research. (LLM, conf=0.89)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Because Klf4 can repress rather than promote axonal growth24, we tested a dual-cistron of only Oct4 and Sox2 and observed no regenerative effect.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
What the sources say
- Supportedcites [24] Moore, D. L. et al. KLF family members regulate intrinsic axon regeneration ability. Science 326, 298–301 (2009). source
The paper’s Abstract identifies KLF4 as a repressor of axon growth in retinal ganglion cells and other CNS neurons. It also reports that KLF4 overexpression reduced axon length in embryonic retinal ganglion cells, directly supporting the cited statement that KLF4 can repress axonal growth. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“If damaged, RGCs of embryos and neonates can regenerate axons, but this capacity is lost within days after birth, likely due to a molecular program intrinsic to the RGCs6,22.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
What the sources say
- Not checked — no full text of the sourcecites [6] Goldberg, J. L., Klassen, M. P., Hua, Y. & Barres, B. A. Amacrine-signaled loss of intrinsic axon growth ability by retinal ganglion cells. Science 296, 1860–1864 (2002). source
- Partly supportedcites [22] Laha, B., Stafford, B. K. & Huberman, A. D. Regenerating optic pathways from the eye to the brain. Science 356, 1031–1034 (2017). sourceExperimental — accuracy not yet measured
The “Intrinsic factors that limit RGC regeneration” section (page not supplied) says RGC axon growth speed falls sharply from embryonic to postnatal ages, likely because of molecular programs intrinsic to RGCs. It does not say that embryonic and neonatal RGCs regenerate after damage or that this capacity is lost within days after birth. (LLM, conf=0.85)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In cell culture, the ectopic expression of the four Yamanaka transcription factors Oct4, Sox2, Klf4, and c-Myc (OSKM) can reprogram cultured somatic cells to become pluripotent stem cells14, a process that erases cellular identity and resets DNAm age4,15.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Not checked — no full text of the sourcecites [14] Takahashi, K. & Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126, 663–676 (2006). source
- Supportedcites [4] Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013). source
The section “DNAm age of induced pluripotent stem cells and stem cells” (page unavailable) describes iPS cells as pluripotent cells derived from non-pluripotent cells by inducing genes. It reports that their DNAm age is significantly younger than that of corresponding primary cells and indistinguishable from embryonic stem cells, supporting the attributed age reset. The specific OSKM factors are attached to a different citation in the citing sentence. (LLM, conf=0.90)
- Supportedcites [15] Petkovich, D. A. et al. Using DNA methylation profiling to evaluate biological age and longevity interventions. Cell Metab. 25, 954–960.e6 (2017). source
The STAR Methods describe reprogramming cultured mouse fibroblasts into iPSCs, consistent with a change from somatic-cell identity to pluripotency. The Results and Discussion report that these iPSCs had much younger estimated DNA-methylation ages than the fibroblasts, while cautioning that the estimates used a clock developed from mouse blood. (LLM, conf=0.88)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Many regenerative approaches that work well in young individuals often fail in older ones25,26.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
What the sources say
- Partly supportedcites [25] Geoffroy, C. G., Hilton, B. J., Tetzlaff, W. & Zheng, B. Evidence for an age-dependent decline in axon regeneration in the adult mammalian central nervous system. Cell Rep. 15, 238–246 (2016). sourceExperimental — accuracy not yet measured
The Abstract and Discussion (page not provided) report that Pten deletion promotes axon regeneration in young mice but has a greatly diminished effect in older mice. The paper tests one approach in mice; it does not establish that many approaches often fail in older individuals, and it describes diminished regeneration rather than complete failure. (LLM, conf=0.85)
- Could not verifycites [26] Yao, K. et al. Restoration of vision after de novo genesis of rod photoreceptors in mammalian retinas. Nature 560, 484–488 (2018). sourceExperimental — accuracy not yet measured
The Abstract describes successful rod-photoreceptor regeneration in mature mouse retinas, with treatment beginning at four weeks of age. Our copy does not compare outcomes in young and older individuals or say that regenerative approaches often fail with age (searched: young versus older regeneration, age-dependent failure). (LLM, conf=0.76)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“In a premature ageing mouse model of Hutchinson-Gilford progeria syndrome (HGPS), cyclic transgene-mediated expression of these four genes alleviates symptoms and extends lifespan, raising the possibility that OSKM might counteract normal ageing, too16.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Supportedcites [16] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719–1733.e12 (2016). source
The Methods describe cyclic doxycycline induction of the OSKM transgene, and the Results report improved appearance and a dramatic increase in median and maximal lifespan in LAKI 4F mice. The paper identifies LAKI as a mouse model of HGPS. The suggestion about normal ageing is the citing authors’ inference, not a finding attributed to this source. (LLM, conf=0.94)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Among the Yamanaka factors, c-Myc is an oncogene that reduces mouse lifespan20 and is not required for the initiation of cellular reprogramming21.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Reset of ageing signatures, not identity
What the sources say
- Supportedcites [20] Hofmann, J. W. et al. Reduced expression of MYC increases longevity and enhances healthspan. Cell 160, 477–488 (2015). source
The Introduction identifies MYC as a cellular proto-oncogene. The Results (‘Myc+/− Mice Have Increased Longevity’; page unavailable) report that mice with reduced MYC expression lived longer than normal Myc+/+ mice, supporting the lifespan claim in that comparison. (LLM, conf=0.85)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Continuous expression of all four factors in normal mice, however, often induces teratomas17–19 or is fatal within days16, ostensibly due to tissue dysplasia18.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Partly supportedcites [17] Ohnishi, K. et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 156, 663–677 (2014). sourceExperimental — accuracy not yet measured
The Results report teratomas after four weeks of factor induction in a small proportion of chimeric mice, and dysplastic lesions in all mice examined after 3–9 days. They also report that induced mice became morbid within days, but do not establish that dysplasia caused death; the sentence cites a different source for the fatality claim. The paper therefore supports the occurrence of teratomas and rapid dysplasia, but not the implied frequency of teratomas or the proposed cause of fatality. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [18] Abad, M. et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 502, 340–345 (2013). source
- Partly supportedcites [19] Senís, E. et al. AAV vector-mediated in vivo reprogramming into pluripotency. Nat. Commun. 9, 2651 (2018). sourceExperimental — accuracy not yet measured
The Results report teratomas in wild-type mice given all four OKSM factors, with high-dose mice developing palpable teratomas after 6–13 weeks. The Introduction mentions dysplasia in a separate study of mice with muscle damage, but this paper does not establish tissue dysplasia as the cause of fatality within days. The within-days fatality clause is cited to a different source (16). (LLM, conf=0.86)
- Supportedcites [16] Ocampo, A. et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 167, 1719–1733.e12 (2016). source
The section “Cyclic In Vivo Induction of Reprogramming Factors Does Not Lead to Tumor Formation” reports high mortality after four days of continuous OSKM induction in 4F mice. The citing sentence attaches this source to the claim of death within days; its teratoma and dysplasia claims have other citations. (LLM, conf=0.93)
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The DNAm age of RGCs was calculated based on a ribosomal DNA methylation clock33, which provided the best site coverage (67/72 CpG sites) and was highly correlated with chronological age (Extended Data Fig. 5g).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK counters injury-induced DNAm ageing
What the sources say
- Partly supportedcites [33] Wang, M. & Lemos, B. Ribosomal DNA harbors an evolutionarily conserved clock of biological aging. Genome Res. 29, 325–333 (2019). sourceExperimental — accuracy not yet measured
The Results section ('CpGs from the rDNA are sufficient to accurately predict age within species'; page unavailable) reports a 72-CpG rDNA clock and a strong correlation between predicted and chronological age in mouse test subsets (median Spearman’s ρ = 0.92). It does not report coverage of 67 of 72 sites, establish that this clock had the best site coverage in the citing study, or test the correlation in RGCs; those appear to be results of the citing study. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Evidence from yeast and mammals supports an Information Theory of Ageing10,11, in which the loss of epigenetic information disrupts youthful gene expression patterns1–3, leading to cellular dysfunction and senescence12,13.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Abstract
What the sources say
- Not matchedcites [10] Sinclair, D. A. & LaPlante, M. D. Lifespan: Why We Age—and Why We Don’t Have To 13–23, 158–175 (Simon & Schuster, 2019).
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Not checked — no full text of the sourcecites [11] Shannon, C. E. A mathematical theory of communication. Bell Syst. Tech. J. 27, 379–423 (1948). source
- Not checked — no full text of the sourcecites [1] Sinclair, D. A., Mills, K. & Guarente, L. Accelerated aging and nucleolar fragmentation in yeast sgs1 mutants. Science 277, 1313–1316 (1997). source
- Not checked — no full text of the sourcecites [2] Imai, S. & Kitano, H. Heterochromatin islands and their dynamic reorganization: a hypothesis for three distinctive features of cellular aging. Exp. Gerontol. 33, 555–570 (1998). source
- Supportedcites [3] Oberdoerffer, P. et al. SIRT1 redistribution on chromatin promotes genomic stability but alters gene expression during aging. Cell 135, 907–918 (2008). source
The Introduction describes chromatin changes causing aging phenotypes in yeast, and the Discussion says the paper presents evidence for a related response in mammals that may contribute to age-related gene-expression changes. This supports the yeast-and-mammal evidence attributed to this citation; the later claims about disrupted gene expression and senescence carry separate citations. (LLM, conf=0.86)
- Partly supportedcites [12] López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M. & Kroemer, G. The hallmarks of aging. Cell 153, 1194–1217 (2013). sourceExperimental — accuracy not yet measured
The Epigenetic Alterations overview (page not provided) says aging is accompanied by epigenetic changes, and the Transcriptional alterations section reports age-related changes in gene expression. The paper also discusses longevity-related evidence from yeast and mammals. It does not set out an Information Theory of Ageing or establish the claimed causal chain from loss of epigenetic information through disrupted youthful expression to cellular dysfunction and senescence. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [13] Yang, J.-H. et al. Erosion of the epigenetic landscape and loss of cellular identity as a cause of aging in mammals. Preprint at https://doi.org/10.1101/808642 (2019). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Not matched
Every source the paper cites for this claim was checked and supports it.
In the paper
“IOPs were measured with a rebound TonoLab tonometer (Colonial Medical Supply, Espoo, Finland), as previously described40.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > IOP measurements
What the sources say
- Supportedcites [40] Krishnan, A. et al. Overexpression of soluble Fas ligand following adeno-associated virus gene therapy prevents retinal ganglion cell death in chronic and acute murine models of glaucoma. J. Immunol. 197, 4626–4638 (2016). source
The Materials and Methods section (‘IOP measurements’; page not provided) explicitly states that IOP was measured with a rebound TonoLab tonometer from Colonial Medical Supply and gives the same location. It also describes the measurement procedure. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Visual acuity of mice was measured using an optomotor reflex-based spatial frequency threshold test58.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Optomotor response
What the sources say
- Supportedcites [58] Sun, D., Moore, S. & Jakobs, T. C. Optic nerve astrocyte reactivity protects function in experimental glaucoma and other nerve injuries. J. Exp. Med. 214, 1411-1430 (2017). source
The Materials and methods section ('Optomotor response') states the claim directly and describes how the spatial frequency threshold was determined in mice. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The number of regenerating axons in the optic nerve was estimated by counting the number of CTB-labeled axons at different distances from the crush site as described previously29.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Quantification of axon regeneration for the optic nerve crush model
What the sources say
- Supportedcites [29] Park, K. K. et al. Promoting axon regeneration in the adult CNS by modulation of the PTEN/mTOR pathway. Science 322, 963–966 (2008). source
The paper’s main text (indexed under Abstract; page unavailable) says it assayed optic-nerve regeneration using CTB-labeled axons in sections across the lesion site. It also reports quantifying regeneration by distance from the lesion epicenter, supporting the described counting method. (LLM, conf=0.88)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“or 248/582 and 77,342/ 193,651 sites (ridge) of two entire lifespan multi-tissue clocks62.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
What the sources say
- Partly supportedcites [62] Thompson, M. J. et al. A multi-tissue full lifespan epigenetic clock for mice. Aging (Albany NY) 10, 2832–2854 (2018). sourceExperimental — accuracy not yet measured
Table 1 in Results (page not provided) lists 582 CpGs for the all-CpGs elastic-net clock and 193,651 for the ridge clock. The paper does not report that 248 or 77,342 of those sites were covered; searches for both coverage figures found no matching passage. (LLM, conf=0.86)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“The mathematical algorithm and available software underlying the skin & blood clock for in vitro studies (based on 391 CpGs) was previously published57.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Human neuron DNA methylation analyses
What the sources say
- Supportedcites [57] Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY) 10, 1758–1775 (2018). source
The Results section, “The DNAm age estimator for skin and blood,” says the clock was constructed from 391 CpGs selected by elastic net regression and describes how their weighted average forms the estimator. The Methods section says the R software code underlying the clock is in the Supplement. (LLM, conf=0.92)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“We chose to use differentiated human neurons that would maintain ageing signatures53.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Human neuron differentiation and regeneration assay
What the sources say
- Partly supportedcites [53] Mertens, J. et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell 17, 705–718 (2015). sourceExperimental — accuracy not yet measured
The Summary reports that directly converted human induced neurons retain aging-associated signatures. It also says that iPSC-derived neurons do not, and the Results section (‘iPSC-Derived iNs Remain Transcriptionally Rejuvenated’) confirms this distinction. The claim is supported only if ‘differentiated human neurons’ means directly converted neurons, not differentiated neurons generally. (LLM, conf=0.88)
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Interestingly, the signature CpG sites were associated with genes involved in synaptic and neuronal processes and enriched for the binding of polycomb repressive complex 2 (PRC2) and its histone methyltransferase product H3K27me3, both of which are known to recruit Tet enzymes47,48 (Extended Data Fig 10g–i).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Restoration of vision in old mice
What the sources say
- Partly supportedcites [47] Wu, X., Li, G. & Xie, R. Decoding the role of TET family dioxygenases in lineage specification. Epigenetics Chromatin 11, 58 (2018). sourceExperimental — accuracy not yet measured
The section on maintenance of hypomethylated promoters says that PRC2 and TET proteins can recruit each other, and Fig. 1 explicitly depicts PRC2 recruiting TETs to bivalent promoters. It describes H3K27me3 as a histone mark at these regions, but does not say that H3K27me3 itself recruits TET enzymes. (LLM, conf=0.88)
- Partly supportedcites [48] Neri, F. et al. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 14, R91 (2013). sourceExperimental — accuracy not yet measured
The Conclusions state that PRC2 recruits Tet1 to H3K27me3 regions in embryonic stem cells (page not specified). The paper does not establish that H3K27me3 itself recruits Tet enzymes, or that this recruitment applies to Tet enzymes generally or to other cell types. (LLM, conf=0.88)
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“compared to 102/435 sites of the whole lifespan multi-tissue clock61”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
What the sources say
- Partly supportedcites [61] Meer, M. V., Podolskiy, D. I., Tyshkovskiy, A. & Gladyshev, V. N. A whole lifespan mouse multi-tissue DNA methylation clock. eLife 7, e40675 (2018). sourceExperimental — accuracy not yet measured
The Results (Construction of a multi-tissue clock; page unavailable) state that the whole-lifespan multi-tissue clock contains 435 CpG sites. The Discussion (page unavailable) reports coverage in other datasets, but neither passage reports 102 covered sites; the cited paper therefore supports the denominator, not the claimed coverage count. (LLM, conf=0.89)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In agreement with previous studies57,63,64, DNAm age estimates of neurons tend to be lower than their chronological age but remain correlated.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
What the sources say
- Supportedcites [57] Horvath, S. et al. Epigenetic clock for skin and blood cells applied to Hutchinson Gilford Progeria Syndrome and ex vivo studies. Aging (Albany NY) 10, 1758–1775 (2018). source
The Results section, “Skin & blood clock applied to brain, liver, bone, and other body parts,” directly reports both findings for sorted neurons: DNAm age correlated strongly with chronological age (r=0.83), while its mean estimate was 6 years in people with a mean chronological age of 31 years. (LLM, conf=0.95)
- Partly supportedcites [63] Horvath, S. et al. The cerebellum ages slowly according to the epigenetic clock. Aging (Albany NY) 7, 294–306 (2015). sourceExperimental — accuracy not yet measured
The Introduction and Methods state that DNAm age correlates with chronological age in sorted neurons. The Results report lower age acceleration for cerebellar brain samples, particularly in the oldest subjects, but do not establish that neurons generally have DNAm age estimates below chronological age. No page numbers are available in our copy. (LLM, conf=0.88)
- Partly supportedcites [64] Hoshino, A., Horvath, S., Sridhar, A., Chitsazan, A. & Reh, T. A. Synchrony and asynchrony between an epigenetic clock and developmental timing. Sci. Rep. 9, 3770 (2019). sourceExperimental — accuracy not yet measured
The Epigenetic clock analysis section (page unavailable) says DNAm age correlates with chronological age in sorted neurons. It does not say neuronal DNAm age estimates tend to be lower than chronological age; the paper’s own reported correlation concerns fetal retinal tissue, not isolated neurons. (LLM, conf=0.86)
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“That said, we do not wish to imply that DNA methylation is the only epigenetic mark involved in this process. It likely involves other transcription factors and epigenetic modifications, such as the PRC2 complex and H3K27me3, both of which are involved in maintaining stem cell plasticity and are associated with DNAm clock sites4,49,50.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Discussion
What the sources say
- Partly supportedcites [4] Horvath, S. DNA methylation age of human tissues and cell types. Genome Biol. 14, 3156 (2013). sourceExperimental — accuracy not yet measured
The section comparing the multi-tissue predictor with other age predictors reports that age-increasing clock CpGs are enriched near Polycomb-group target genes; the Additional file 9 description also links them to SUZ12, EED and H3K27me3 occupancy. The paper does not establish that PRC2, H3K27me3 or other transcription factors participate in the process the citing sentence proposes, or that their role in maintaining stem-cell plasticity explains the clock-site association. (LLM, conf=0.85)
- Partly supportedcites [49] Margueron, R. & Reinberg, D. The Polycomb complex PRC2 and its mark in life. Nature 469, 343–349 (2011). sourceExperimental — accuracy not yet measured
The sections on genome-wide localization and PRC2 pluripotency and differentiation link PRC2 and H3K27me3 to stem-cell chromatin states and plasticity, though they qualify PRC2’s role in maintaining pluripotency. The paper discusses DNA methylation alongside these marks, but it does not address DNAm clock sites or establish their involvement in the citing paper’s specific process. (LLM, conf=0.82)
- Partly supportedcites [50] Mozhui, K. & Pandey, A. K. Conserved effect of aging on DNA methylation and association with EZH2 polycomb protein in mice and humans. Mech. Ageing Dev. 162, 27–37 (2017). sourceExperimental — accuracy not yet measured
The Introduction and Discussion §4.4 identify PRC2 as a potential regulator of age-related DNA methylation, and Results §3.5 reports that PRC2 members associate with age-hypermethylated regions. The passages do not establish the attributed role of H3K27me3 or the claim that both PRC2 and H3K27me3 maintain stem-cell plasticity and are associated with DNA-methylation clock sites. No page numbers are available in our copy. (LLM, conf=0.85)
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Another 196 genes that were up-regulated during ageing are involved in ion transport or neuronal projection development, including Efemp1 (Extended Data Fig. 10b–d), a Tet1- and Tet2-regulated gene associated with glaucoma45 and age-related macular degeneration (AMD)46.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Restoration of vision in old mice
What the sources say
- Supportedcites [45] Mackay, D. S., Bennett, T. M. & Shiels, A. Exome sequencing identifies a missense variant in EFEMP1 co-segregating in a family with autosomal dominant primary open-angle glaucoma. PLoS ONE 10, e0132529 (2015). source
The citation to this paper follows “glaucoma,” so the relevant attribution is EFEMP1’s association with glaucoma, not the citing authors’ Tet1/Tet2 finding or the separately cited AMD association. The Discussion reports an EFEMP1 variant co-segregating with primary open-angle glaucoma in an affected family. (LLM, conf=0.93)
- Not checked — no full text of the sourcecites [46] Marmorstein, L. Y. et al. Aberrant accumulation of EFEMP1 underlies drusen formation in Malattia Leventinese and age-related macular degeneration. Proc. Natl Acad. Sci. USA 99, 13067–13072 (2002). source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
- Supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“In 12-month-old mice, OSK treatment doubled RGC survival, similar to what was observed in 1- and 3-month-old mice (Extended Data Fig. 4a).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even without c-Myc, expression of OSK for five days promoted youthful mRNA profile, with no apparent loss of cellular identity or the induction of Nanog, a transcription factor indicative of pluripotency and oncogenicity (Extended Data Fig. 1a–c).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Reset of ageing signatures, not identity
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“After 10–18 months of continuous OSK induction, no increase in tumor incidence or negative effects on overall health were observed, indicating that cellular identity was maintained in OSK-expressing cells (Extended Data Fig.1 j–n).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Reset of ageing signatures, not identity
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The longer the duration of the OSK induction, the greater the distance the axons extended, with no sign of RGC proliferation (Fig. 2b, c, Extended Data Fig. 5f).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK counters injury-induced DNAm ageing
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The mRNA levels of Stat3, a pro-regeneration gene28, robustly increased in response to OSK and was maintained post-injury (Extended Data Fig. 5a, Supplementary Table 1).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Even after 15 months of continuous induction, OSK expression did not induce any tumors or structural changes in the retina (Extended Data Fig. 2c–i, Supplementary Videos).”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“67/72 sites with at least 10 reads per site were covered for the ribosomal DNAm clock”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“OSK-mediated recovery of neurite area, as well as both the number and length of axons, were blocked by Tet2 knockdown, but not by mTOR-S6K inhibition (Extended Data Fig. 8j–s).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Axon regeneration in human neurons
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Of the 703,583 CpGs that were considered, 1,226 were selected (723 that trended towards hypermethylation with age and 503 that trended towards hypomethylation with age, see Supplementary Table 3).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNAm ageing signature
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“This resulted in a total of 703,583 sites, covered by uniquely mapped reads.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The OSK-treated eyes also experienced a significant increase in visual acuity relative to the pre-treatment function baseline, restoring about half of visual acuity in the optomotor response (OMR) assay (Fig. 3c, d).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Recovery of vision in mice with glaucoma
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Interestingly, the signature CpG sites were associated with genes involved in synaptic and neuronal processes and enriched for the binding of polycomb repressive complex 2 (PRC2) and its histone methyltransferase product H3K27me3, both of which are known to recruit Tet enzymes47,48 (Extended Data Fig 10g–i).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Restoration of vision in old mice
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“DNA demethylation is catalyzed by ten-eleven-translocation methylcytosine dioxygenases (TET1–3), either passively through DNA replication or actively, even in non-replicating cells, by reversion to cytosine via thymine DNA glycosylase (TDG)34.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Regeneration requires DNA demethylation
What the sources say
- Not checked — no full text of the sourcecites [34] Wu, X. & Zhang, Y. TET-mediated active DNA demethylation: mechanism, function and beyond. Nat. Rev. Genet. 18, 517–534 (2017). source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Thus, the ability of OSK to increase survival appears to be mediated within the RGC and is largely cell-autonomous.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Attempts to reverse optic nerve damage have been only moderately successful, with no treatments able to restore eyesight either in late-stage glaucoma or in old age23.”
§ Reprogramming to recover youthful epigenetic information and restore vision > OSK stimulates axon regeneration
What the sources say
- Not checked — no full text of the sourcecites [23] Roska, B. & Sahel, J. A. Restoring vision. Nature 557, 359–367 (2018). source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Cells were confirmed as negative for mycoplasma”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Human neuron differentiation and regeneration assay
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“RNA integrity was determined using TapeStation (Agilent Technologies, Palo Alto, CA, USA).”
- Also stated in: § Ultra-low input RNA library preparation and multiplexing · plain
“RNA integrity was ascertained using a 2100 TapeStation (Agilent Technologies, Palo Alto, CA, USA).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Total RNA extraction and sample quality control
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
- Also stated in: § Ultra-low input RNA library preparation and multiplexing · plain
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All animal procedures were approved by the IACUC of the respective institutions and according to appropriate animal welfare regulations.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Surgery
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Any mice that developed signs of inflammation (clouding or an edematous cornea) were excluded.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Microbead-induced elevated intraocular pressure (IOP)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A sensitivity analysis was conducted by performing TF and histone enrichment for five sets of 1,226 random CpGs from the 702,357 unselected sites, which was then compared against the enrichment for our selected set in in order to identify TFs and histone marks that were specific to the selected set but not CpGs in general.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Transcription factor (TF) binding and histone modification enrichment
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All cell lines used were mycoplasma negative.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Cell culture of ear fibroblasts
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: fails — The paper may give no reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. The paper may give no reason why it holds.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“PI-stained samples were analyzed on a BD LSR II analyzer and only single cells were gated for analysis.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Cell cycle analysis
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two outliers were excluded by low intercorrelation (< 0.93) within the batch (Supplementary Table 5).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Two individuals blinded to the experimental groups performed all RGC counts.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Quantification of retinal ganglion cells in the glaucoma model
plainn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“A blinded observer, unable to see the direction of the moving bars, monitored the tracking behavior of the mouse.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Optomotor response
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Mice that had intravitreal bleeding or developed signs of inflammation (clouding or an edematous cornea) during or post intravitreal injection were excluded from OMR and histological analyses.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Optomotor response
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“The final library was assessed by a Qubit 2.0 Fluorometer and an Agilent TapeStation.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Ultra-low input RNA library preparation and multiplexing
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Only CpG sites covered in all samples were considered for analysis (BioProject PRJNA655981).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All IOPs were taken at the same time of day (between 10:00 and 12:00 hrs) due to the variation of IOP throughout the day.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > IOP measurements
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“All animal work was approved by the Institutional Animal Care and Use Committees (IACUCs) at Harvard Medical School, Boston Children’s Hospital, and the Mass Eye and Ear Institution.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Mouse lines
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Exclusion criteria were pre-determined before experimentation.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Optomotor response
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Individuals performing axon counts were blinded to the experimental groups.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Quantification of optic nerve axons in the glaucoma model
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Using the eye as a model system, we present evidence that ectopically expressed OSK safely induces in vivo epigenetic restoration of aged CNS neurons, without causing a loss of cell identity or pluripotency.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Discussion
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Here, we show that it is possible to safely reverse the age of a complex tissue and restore its biological function in vivo.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Discussion
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“Due to the repetitive nature of ribosomal DNA sequence, it is not suitable to whole-genome bisulfite mapping.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNA methylation analysis of mouse RGC
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“Responses were measured before and after treatment by individuals blinded to the group of the animal and the treatment.”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Optomotor response
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
What the paper did — it cites no source for this, so there is none to check. The quote shows it is in the paper.
In the paper
“To avoid batch effects, subsamples were evaluated separately as 6 mo and 18 mo in Batch 1, and 1 mo, 12 mo, and 30 mo in Batch 2 (Supplementary Table 5).”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > DNAm ageing signature
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
The paper relies on this without support.
DNA methylation patterns are established during embryonic development to set cell type and function.
“DNA methylation patterns are laid down during embryonic development to establish cell type and function.”
The paper relies on this without support.
During ageing, almost all species experience a decline in regenerative potential.
“During ageing, almost all species experience a decline in regenerative potential.”
The paper relies on this without support.
Currently, there is no known treatment that can induce robust RGC axon regeneration when started after crush injury.
“Currently, there is no known treatment that can induce robust RGC axon regeneration when started after crush injury.”
The paper relies on this without support.
Glaucoma is a leading cause of age-related blindness worldwide, characterized by progressive loss of RGCs and their axons and often coinciding with increased intraocular pressure.
“Glaucoma is a leading cause of age-related blindness worldwide, characterized by a progressive loss of RGCs and their axons and often coinciding with increased intraocular pressure (IOP).”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“and active DNA methylation via TET and TDG enzymes is required for rejuvenation 92 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These findings are consistent with the Information Theory of Aging, which proposes that a decline in information, specifically epigenetic information, triggers a cascade of events, including mitochondrial dysfunction, inflammation, and cellular senescence [5, 7–9], leading to a progressive decline in cell and tissue function, manifesting as aging and age-related diseases.”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Numerous tissues, including brain tissue, kidney, and muscle, have now been reprogrammed without causing cancer [7, 8, 22, 24, 25].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Currently, translational applications that aim to reverse aging, treat injuries, and cure age-related diseases, rely on the delivery of genetic material to target tissues.”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent advances have shown that such regeneration is possible in mice and humans25,26.”
From The economic value of targeting aging (2021) · cites this paper as [26]
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“This transient cellular perturbation, variously known as 'partial' , ' transient ' or ' intermediate ' reprogramming, is able to rejuvenate cellular markers of aging such as the DNA methylation clock, DNA damage, epigenetic patterns and aging-associated changes in the transcriptome, both in vitro and in vivo 213 -217 .”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [215]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There is also evidence that changes to methylation occur in parallel with the observed alteration in chromatin contacts, and active DNA methylation via TET and TDG enzymes is required for rejuvenation 92 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“this study is also the first to show that cellular damage accelerates epigenetic aging”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“whole-body overexpression of OSK for a year was found to have no observable negative effects”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“the ectopic and constant expression of OSK in retinal ganglion cells in vivo is able to restore vision by promoting axon regeneration in aged and glaucomatous mice without increasing cell proliferation (Fig. 3g).”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“further supporting the idea that specific levels of OSK expressions of the elements in addition to cell identity are essential to exert optimal function.”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We have previously shown that the ectopic induction of the Yamanaka factors OCT4, SOX2, and KLF4 (OSK) in mammals can restore youthful DNA methylation patterns, transcript profiles, and tissue function, without erasing cellular identity”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“We have previously shown that the ectopic induction of the Yamanaka factors OCT4, SOX2, and KLF4 (OSK) in mammals can restore youthful DNA methylation patterns, transcript profiles, and tissue function, without erasing cellular identity”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“But work by the Belmonte lab, our lab, and others have confirmed that it is possible to safely improve the function of tissues in vivo by pulsing OSKM expression [22, 23] or by continuously expressing only OSK, leaving out the oncogene c-MYC [7, 8].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“In the optic nerve, for example, expression of a three Yamanaka factor combination safely resets DNA methylomes and gene expression patterns, improving vision in old and glaucomatous mice via a largely obscure mechanism that requires TET DNA demethylases [8].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“We have previously shown that the ectopic induction of the Yamanaka factors OCT4, SOX2, and KLF4 (OSK) in mammals can restore youthful DNA methylation patterns, transcript profiles, and tissue function, without erasing cellular identity”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“We have previously shown that the ectopic induction of the Yamanaka factors OCT4, SOX2, and KLF4 (OSK) in mammals can restore youthful DNA methylation patterns, transcript profiles, and tissue function, without erasing cellular identity”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Together, these results are consistent with the existence of a “back-up copy” of a youthful epigenome, one that can be reset via partial reprogramming to regain tissue function, without erasing cellular identity or causing tumorigenesis [7–9].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Ectopic expression of Yamanaka factors OCT4, SOX2, and KLF4 (OSK) restores youthful gene expression patterns, epigenetic age, and youthful functions to old cells and tissues [7, 8].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Given that VC6TF has not been reported to be capable of fully reprogramming human cells to CiPSCs, and the maximum duration of any chemical treatment was limited to only four days, this study substantiates the notion that the rejuvenation is inherent to early phases of reprogramming and is at least partially separable from pluripotency programs [7, 8].”
From Chemically induced reprogramming to reverse cellular aging (2023) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“Besides amelioration of cellular aging hallmarks, reprogramming factors promote tissue regeneration in aged mice8,10.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Reprogramming factors have been shown to promote axon regeneration through intrinsic rejuvenation of retinal ganglion cells10.”
From In vivo partial reprogramming of myofibers promotes muscle regeneration by remodeling the stem cell niche (2021) · cites this paper as [10]
The cited source says what the claim attributes to it.
In the citing paper
“Also, tissue dysfunctions characteristic of natural aging, such as reduced visual acuity 215 and the loss of adult neurogenesis in the hippocampus and long-term memory 220 , can be partially reversed by transient reprogramming.”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [215]
The cited source says what the claim attributes to it.
In the citing paper
“This increased repair capacity has been shown for models of tissue damage in the endocrine pancreas 214 , skeletal muscle 214 , nerve fibers 215 , eye 215 , skin 216 , heart 218 and liver 219 .”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [215]
The cited source says what the claim attributes to it.
In the citing paper
“| Stem cell exhaustion | Mouse | AAV2-driven expression of OSK in the eye | Restoration of visual acuity to old mice and to mice with glaucoma. Improved repair of crushed optical nerve | 215”
From Hallmarks of aging: An expanding universe (2023) · cites this paper as [215]
The cited source says what the claim attributes to it.
In the citing paper
“and that long-term reprogramming can be achieved using a specific subset of reprogramming factors came from Lu et al. in 2020 (ref.92).”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting that MYC might be responsible for some of the toxicity.”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“some studies have not seen any detriment to tissues after more than a year of overexpression 92”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“indicating a critical role for dynamic DNA methylation during partial reprogramming.”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“The demonstration that the DNA methylation clock can be reversed in vivo by reprogramming”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“a change that OSK counteracts to allow cells to regain youthful gene expression patterns and functions.”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“Similar results were also obtained in human neurons”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“when OSK were co-delivered as monocistronic vectors, no axon regeneration was observed”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“suggesting an evolutionarily conserved mechanism 92 .”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“the observed regenerative phenotype is mediated by the active contribution of TET1 and TET2 DNA demethylases and the TDG DNA glycosylase”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
The cited source says what the claim attributes to it.
In the citing paper
“induction of the factors both before and after the optical nerve injury led to increased regeneration capability of retinal ganglion cells.”
From Mechanisms, pathways and strategies for rejuvenation through epigenetic reprogramming (2023) · cites this paper as [92]
In the citing paper
“Epigenetic alteration is a hallmark of ageing4, and recent studies have demonstrated cellular and functional rejuvenation by transient epigenetic reprogramming17,51,52.”
From Measuring biological age using omics data (2022) · cites this paper as [17]
In the citing paper
“Lu et al.17 found that DNA methylation enzymes were required for epigenetic reprogramming of mouse retinal cells but much more work is needed.”
From Measuring biological age using omics data (2022) · cites this paper as [17]
In the citing paper
“Reprogramming factors also affect differentiated cells in the brain: viral transduction of cells in vivo with OSK (no MYC) restores a youthful regenerative potential of axons emanating from aged mouse retinal ganglion cells231.”
From Ageing and rejuvenation of tissue stem cells and their niches (2023) · cites this paper as [231]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Quantification of retinal ganglion cells in the glaucoma model
“two to four images (248.53 μm by 248.53 μm in size) were taken from the midperipheral and peripheral regions of each quadrant”
§ Reprogramming to recover youthful epigenetic information and restore vision > Methods > Quantification of retinal ganglion cells in the glaucoma model
“all Brn3a stained RGCs within each image (0.025 mm2)”
Citations
Cites
A Mathematical Theory of Communication
Shannon, C. E. (1948) · Bell System Technical Journal · doi:10.1002/j.1538-7305.1948.tb01338.x · Cited by 88,486
Gene Ontology: tool for the unification of biology
Ashburner, M., Ball, C. A., Blake, J. A., Botstein, D., Butler, H., Cherry, J. M., Davis, A. P., Dolinski, K., Dwight, S. S., Eppig, J. T., et al. (2000) · Nature Genetics · doi:10.1038/75556 · Cited by 43,206
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Liao, Y., Smyth, G. K., & Shi, W. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btt656 · Cited by 27,219
Takahashi, K., & Yamanaka, S. (2006) · Cell · doi:10.1016/j.cell.2006.07.024 · Cited by 26,673
HISAT: a fast spliced aligner with low memory requirements
Kim, D., Langmead, B., & Salzberg, S. L. (2015) · Nature Methods · doi:10.1038/nmeth.3317 · Cited by 24,112
López-Otín, C., Blasco, M. A., Partridge, L., Serrano, M., & Kroemer, G. (2013) · Cell · doi:10.1016/j.cell.2013.05.039 · Cited by 14,982
DNA methylation age of human tissues and cell types
Horvath, S. (2013) · Genome Biology · doi:10.1186/gb-2013-14-10-r115 · Cited by 7,075
Self-citationThe Gene Ontology Resource: 20 years and still GOing strong
The Gene Ontology Consortium (2019) · Nucleic Acids Research · doi:10.1093/nar/gky1055 · Cited by 4,747
The Polycomb complex PRC2 and its mark in life
Margueron, R., & Reinberg, D. (2011) · Nature · doi:10.1038/nature09784 · Cited by 3,347
Cited by
Sorted by citations
Items 201–300 of 822
Reprogramming cellular identity in vivo
Leaman, S., Marichal, N., & Berninger, B. (2022) · Development · doi:10.1242/dev.200433 · Cited by 22
Epigenetic aging in adult neurogenesis
Zocher, S., & Toda, T. (2023) · Hippocampus · doi:10.1002/hipo.23494 · Cited by 29
“Moreover, cellular reprogramming of aged cells to a youthful functional state depends on the removal of DNA methylation marks in aged cells (Lu et al., 2020).”
BackgroundPopescu, I. R., Deelen, J., Illario, M., & Adams, J. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17912 · Cited by 28
Todorova, M. N., Savova, M. S., Mihaylova, L. V., & Georgiev, M. I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010352 · Cited by 26
“Furthermore, the distinction between what constitutes aging and how we interpret it, either chronologically or biologically, has contributed to the expansion of this field of scientific research [1,4,5].”
BackgroundAxon Regeneration: A Subcellular Extension in Multiple DimensionsPreprint
Winter, C. C., He, Z., & Jacobi, A. (2021) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a040923 · Cited by 26
Self-citationChemical reprogramming ameliorates cellular hallmarks of aging and extends lifespan
(2025) · doi:10.1038/s44321-025-00265-9 · Cited by 49
“…tissues and organs including the intervertebral disc, heart, skin, skeletal muscle, liver, optic nerve, and dentate gyrus (Ocampo et al, 2016b; Kurita et al, 2018; de Lázaro et al, 2019; Lu et al, 2020; Rodríguez-Matellán et al, 2020; Chen et al, 2021; Cheng et al, 2022; Hishida et al, 2022).”
Maiti, S., Bhattacharya, K., Wider, D., Hany, D., Panasenko, O. O., Bernasconi, L., Hulo, N., & Picard, D. (2023) · eLife · doi:10.7554/elife.88658 · Cited by 31
The Relaxin-3 Receptor, RXFP3, Is a Modulator of Aging-Related Disease
Leysen, H., Walter, D., Clauwaert, L., Hellemans, L., van Gastel, J., Vasudevan, L., Martin, B., & Maudsley, S. R. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084387 · Cited by 20
Circular RNAs regulate parental gene expression: A new direction for molecular oncology research
Wang, H., Gao, X., Yu, S., Wang, W.-N., Liu, G., Jiang, X., & Sun, D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.947775 · Cited by 25
“Frontiers in Oncology 05 dioxygenase 1) in the promoter region of the host gene FLI1 to directly induce DNA demethylation of the parent gene, thereby regulating the transcriptional activity of the target gene FLI1 (58).”
BackgroundInfluentialHow can we modulate aging through nutrition and physical exercise? An epigenetic approach
Rajado, A. T., Silva, N., Esteves, F., Brito, D. V. C., Binnie, A., Araújo, I. M., Nóbrega, C., Bragança, J., & Castelo‐Branco, P. (2023) · Aging · doi:10.18632/aging.204668 · Cited by 32
Multi-omic rejuvenation of human cells by maturation phase transient reprogrammingPreprint
Gill, D., Parry, A., Santos, F., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.15.426786 · Cited by 25
Anti-senescence therapies: a new concept to address cardiovascular disease
Stojanović, S. D., Thum, T., & Bauersachs, J. K. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf030 · Cited by 32
The ageing immune system as a driver of systemic ageing
Jang, I. H., Niedernhofer, L. J., Robbins, P. D., & Camell, C. D. (2026) · Nature reviews. Immunology · doi:10.1038/s41577-026-01269-3 · Cited by 35
“Delivery of OSKM by viral gene transfer with a regulated promoter or transiently using mRNA transfection has shown evidence of rejuvenation in specific tissues in vivo 181,182 .”
Chilunga, F. P., Henneman, P., Elliott, H. R., Cronjé, H. T., Walia, G. K., Meeks, K. A. C., Requena‐Méndez, A., Venema, A., Bahendeka, S., Danquah, I., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00087-8 · Cited by 28
Epigenetic modifications of histones during osteoblast differentiation
Adithya, S. P., Balagangadharan, K., & Selvamurugan, N. (2021) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2021.194780 · Cited by 25
Rejuvenation of Tissue Stem Cells by Intrinsic and Extrinsic Factors
Cai, Y., Wang, S., Qu, J. T., Belmonte, J. C. I., & Liu, G. (2021) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szab012 · Cited by 28
Cellular reprogramming and the rise of rejuvenation biotech
de Magalhães, J. P., & Ocampo, A. (2022) · Trends in biotechnology · doi:10.1016/j.tibtech.2022.01.011 · Cited by 25
Reece, A. S., & Hulse, G. K. (2022) · Archives of Public Health · doi:10.1186/s13690-022-00812-7 · Cited by 24
“They were also able to reverse the aging of advanced mouse retinae, restore the transcriptome to young again and improve sight [98].”
BackgroundInfluentialNatural killer cells act as an extrinsic barrier for in vivo reprogramming
Melendez, E., Chondronasiou, D., Mosteiro, L., de Villarreal, J. M., Fernández‐Alfara, M., Lynch, C. J., Grimm, D., Real, F. X., Alcamı́, J., Climent, N., et al. (2022) · Development · doi:10.1242/dev.200361 · Cited by 26
Clerck, K. D., Accou, G., Sauvage, F., Braeckmans, K., Smedt, S. C. D., Remaut, K., & Peynshaert, K. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081716 · Cited by 24
“However, while highly effective to target photoreceptor cells (PRs) and the retinal pigment epithelium (RPE), new pioneering therapeutic strategies such as neuroprotection [5], optogenetics [6] and reprogramming [7] demand delivery to target cells located in the inner retina.”
BackgroundZhou, X., Rong, R., Liang, G., Li, H., You, M., Zeng, Z., Xiao, H., Ji, D., & Xia, X. (2022) · Nano Today · doi:10.1016/j.nantod.2022.101668 · Cited by 24
DNA methylation markers of age(ing) in non‐model animals
Tangili, M., Slettenhaar, A. J., Sudyka, J., Dugdale, H. L., Pen, I. R., Palsbøll, P. J., & Verhulst, S. (2023) · Molecular Ecology · doi:10.1111/mec.17065 · Cited by 24
Zhang, Q., Xue, J., Tang, J., Wu, S., Liu, Z., Wu, C., Liu, C., Liu, Y., Lin, J., Han, J., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado0866 · Cited by 26
“We also evaluated the optomotor response (OMR) to assess visual acuity in mice ( 74 ).”
Self-citationBody-wide multi-omic counteraction of aging with GLP-1R agonism
Huang, J., Kwok, A. J., Li, J. C. Y., Chiu, C. L. H., Ip, B. Y. M., Tung, L. Y., Chan, R. C. H., Chan, D. T.-M., Wang, Z., Zheng, X., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.10.014 · Cited by 31
Animals Models of Inherited Retinal Disease
Moshiri, A. (2021) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000368 · Cited by 23
Mokhtari, R. B., Sambi, M., Qorri, B., Baluch, N., Ashayeri, N., Kumar, S., Cheng, H. M., Yeger, H., Das, B., & Szewczuk, M. R. (2021) · Cancers · doi:10.3390/cancers13143596 · Cited by 25
Morel, G., Chiavellini, P., Canatelli-Mallat, M., Lehmann, M., & Goya, R. G. (2021) · Neural Regeneration Research · doi:10.4103/1673-5374.320966 · Cited by 24
“Thus, it has been shown that the delivery of the OSK genes by intravitreally injecting a regulatable adeno-associated viral vector type 2 (AAV2) expressing the polycistron OSK can reverse vision deficits in two mouse models (Lu et al., 2020).”
BackgroundTurning back time with epigenetic clocks
Drew, L. (2022) · Nature · doi:10.1038/d41586-022-00077-8 · Cited by 22
Impaired disassembly of the axon initial segment restricts mitochondrial entry into damaged axons
Kiryu-Seo, S., Matsushita, R., Tashiro, Y., Yoshimura, T., Iguchi, Y., Katsuno, M., Takahashi, R., & Kiyama, H. (2022) · EMBO Journal · doi:10.15252/embj.2021110486 · Cited by 18
“Recent progresses have clarified that the transcriptional and epigenetic reprogramming makes injured neurons revert to immature state for regeneration (Chandran et al , 2016; Palmisano et al , 2019; Bradke et al , 2020; Lu et al , 2020; Renthal et al , 2020).”
Innate immunity dysregulation in aging eye and therapeutic interventions
Das, S., Ahmad, Z., Suryawanshi, A. S., & Kumar, A. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101768 · Cited by 24
New Insights into the Genetics and Epigenetics of Aging Plasticity
Zhang, J., Wang, S., & Liu, B. (2023) · Genes · doi:10.3390/genes14020329 · Cited by 25
“Using adeno-associated virus (AAV) to introduce three transcription factors, Oct4, Sox2, and Klf4 (OSK) in aging mice, age-associated visual impairments were successfully reversed [110].”
MethodNo Time to Age: Uncoupling Aging from Chronological Time
Larocca, D., Lee, J., West, M. D., Labat, I., & Sternberg, H. (2021) · Genes · doi:10.3390/genes12050611 · Cited by 22
“Two recent studies provide evidence suggesting that a reversal of the DNAm clock during in vivo reprogramming may be possible (169, 170).”
BackgroundInfluentialDhokia, V., Albati, A., Smith, H., Thomas, G., & Macip, S. (2024) · Biochemical Society Transactions · doi:10.1042/bst20231066 · Cited by 26
Expansion of the neocortex and protection from neurodegeneration by in vivo transient reprogramming
Shen, Y.-R., Zaballa, S., Bech, X., Sancho‐Balsells, A., Rodríguez-Navarro, I., Cifuentes-Díaz, C., Seyit-Bremer, G., Chun, S. H., Straub, T., Abante, J., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.09.013 · Cited by 26
CHIPing away the progression potential of CHIP: A new reality in the making
Xie, Z., & Zeidan, A. M. (2022) · Blood Reviews · doi:10.1016/j.blre.2022.101001 · Cited by 22
Autonomous AI Agents Discover Aging Interventions from Millions of Molecular ProfilesPreprint
Ying, K., Tyshkovskiy, A., Moldakozhayev, A., Wang, H., Magalhães, C. G. D., Iqbal, S., Garza, A. E., Tskhay, A., Poganik, J. R., Huang, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.02.28.530532 · Cited by 24
Self-citationGenome-wide chromatin accessibility analyses provide a map for enhancing optic nerve regeneration
Pita‐Thomas, W., Gonçalves, T. M., Kumar, A., Zhao, G., & Cavalli, V. (2021) · Scientific Reports · doi:10.1038/s41598-021-94341-y · Cited by 20
Reece, A. S., & Hulse, G. K. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100245 · Cited by 21
“These data are particularly significant in the context of increasing international concern relating to the generationally transmissible effects of genotoxicity and epigenotoxicity from cannabinoids [7,9,10].”
Does Modulation of an Epigenetic Clock Define a Geroprotector?
Schork, N. J., Beaulieu‐Jones, B. K., Liang, W. S., Smalley, S. L., & Goetz, L. H. (2022) · Advances in Geriatric Medicine and Research · doi:10.20900/agmr20220002 · Cited by 23
Guan, Y., Chen, X., Shao, B., Ji, X., Xiang, Y., Jiang, G., Xu, L., Lin, Z., Ouyang, Q., & Lou, C. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00073 · Cited by 18
Rheaume, B. A., Xing, J., Łukomska, A., Theune, W. C., Damania, A., Sjogren, G., & Trakhtenberg, E. F. (2023) · Development · doi:10.1242/dev.201644 · Cited by 20
Vanluchene, H., Gillon, O., Peynshaert, K., Smedt, S. C. D., Sanders, N. N., Raemdonck, K., & Remaut, K. (2024) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2024.114204 · Cited by 19
Aging and rejuvenation - a modular epigenome model
Chiavellini, P., Canatelli-Mallat, M., Lehmann, M., Gallardo, M. D., Hereñú, C. B., Cordeiro, J. L., Clement, J., & Goya, R. G. (2021) · Aging · doi:10.18632/aging.202712 · Cited by 21
“In contrast, DOXinduced expression of OSK in OSK transgenic mice, induced rapid weight loss and death, likely due to severe dysplasia in the digestive system [50].”
BackgroundEpigenome–metabolism nexus in the retina: implications for aging and disease
Mondal, A. K., Gaur, M., Advani, J., & Swaroop, A. (2024) · Trends in Genetics · doi:10.1016/j.tig.2024.04.012 · Cited by 20
“Accelerated DNAm age is reported in ribosomal DNAm clock of injured retinal ganglion cells [131].”
Epigenetic Clocks: Beyond Biological Age, Using the Past to Predict the Present and Future
Liang, R., Tang, Q., Chen, J., & Zhu, L. (2024) · Aging and Disease · doi:10.14336/ad.2024.1495 · Cited by 28
Reece, A. S., & Hulse, G. K. (2022) · Current Zoology · doi:10.1093/eep/dvac006 · Cited by 21
CD82 protects against glaucomatous axonal transport deficits via mTORC1 activation in mice
Ye, M., Huang, J., Mou, Q., Luo, J., Hu, Y., Lou, X., Yao, K., Zhao, B., Duan, Q., Li, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04445-6 · Cited by 19
“To date, most approaches aimed to improve different neuron intrinsic capacities, such as targeting key signaling pathways [50, 51], manipulating transcription factors [40], and regulating epigenetic mechanisms [52].”
BackgroundMethodGas5 inhibition promotes the axon regeneration in the adult mammalian nervous system
Han, X., Xu, J., Chen, Z., Li, P., Zhao, L., Tao, J., Yu, S., Zhu, S., Yu, B., Zhu, J., et al. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114157 · Cited by 20
Self-citationCvekl, A., & Camerino, M. J. (2022) · Cells · doi:10.3390/cells11213516 · Cited by 24
Optic Nerve Regeneration in Diabetic Retinopathy: Potentials and Challenges Ahead
Wu, S., & Mo, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021447 · Cited by 20
“In a recent study, forced overexpression of three Yamanaka stem cell factors, KLF-4, SOX2 and octamer-binding transcription factor 4 (OCT4), induced global DNA demethylation and successful axon regeneration, with some axons extending to the chiasm [87] after optic nerve crush.”
BackgroundVitamin C protects retinal ganglion cells via SPP1 in glaucoma and after optic nerve damage
Li, S., & Jakobs, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202301976 · Cited by 22
“…(Pease et al, 2009; Yang et al, 2016; Pham et al, 2022; Lazaldin et al, 2023), improving mitochondrial function (Ju et al, 2022; Quintero et al, 2022), and preventing the detrimental changes that are common to glaucomatous and age-related degeneration of RGCs (Lu et al, 2020; Xu et al, 2022).”
BackgroundSenescent endothelial cells promote liver metastasis of uveal melanoma in single-cell resolution
Ma, L., He, X., Fu, Y., Ge, S., & Yang, Z. H. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05430-1 · Cited by 22
“KLF4 is a very important transcription factor with a major role in cell cycle regulation and cell differentiation [24].”
BackgroundExposure to ionizing radiation disrupts normal epigenetic aging in Japanese medaka
Bertucci, E. M., Mason, M. W., Rhodes, O. E., & Parrott, B. B. (2021) · Aging · doi:10.18632/aging.203624 · Cited by 26
“Lastly, we created an age predictor based off of a principal components analysis (PCA) of age-associated cytosines in the training set (as determined by Spearman correlation coefficients > 0.5 or < -0.5; n = 304), similar to the approach done in Lu et al. 2020 [68].”
InfluentialKovacs, K. D., Ciulla, T. A., & Kiss, S. (2022) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2022.2121646 · Cited by 20
“This leads to a reversal of age-related DNA methylation and regeneration of retinal ganglion cell axons, showing reversal of vision loss in mouse studies to date [56].”
BackgroundXia, X., Shi, C., Tsien, C. I., Sun, C. B., Xie, L., Luo, Z., Bian, M., Russano, K. R., Thakur, H. S., Benowitz, L. I., et al. (2024) · eNeuro · doi:10.1523/eneuro.0478-23.2024 · Cited by 18
“It will be important to understand whether CaMKII treatment is effective in the context of additional proregenerative treatments, including in PTEN or KLF9 gene deletion or Oct4, Sox2, or Klf4 overexpression (Park et al., 2008; Moore et al., 2009; Lu et al., 2020), among others.”
BackgroundCell-based regenerative and rejuvenation strategies for treating neurodegenerative diseases
Deng, S., Xie, H., & Xie, B. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04285-7 · Cited by 24
“When inducible OSK-containing AAV9 was delivered to the retinal ganglion cells of old mice via intravenous delivery, continuous expression of OSK factors led to a partially restored vision [262].”
Targeting the chromatin remodeler BAZ2B mitigates hepatic senescence and MASH fibrosis
Tu, C., Cheng, Q., Li, S., Lin, D.-Y., Liu, Z.-Y., Ouyang, W.-G., Kang, X.-L., Chen, F., Song, S., & Cai, S. (2025) · Nature Aging · doi:10.1038/s43587-025-00862-w · Cited by 21
Pernomian, L., Waigi, E. W., Nguyen, V., Mohammed, A. D., Costa, T. J. D., Fontes, M. T., Kubinak, J. L., Aitken, A. V., Biancardi, V. C., Gleason, K., et al. (2025) · Circulation Research · doi:10.1161/circresaha.124.324909 · Cited by 21
Self-citationNext-Generation Gene Therapy for Parkinson’s Disease Using Engineered Viral Vectors
Björklund, T., & Davidsson, M. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212674 · Cited by 22
“While very early days, such therapies could target macroautophagy [55], slow down neuronal aging [56, 57] or even rejuvenate the dopamine neurons [58].”
Combining stem cell rejuvenation and senescence targeting to synergistically extend lifespan
Kaur, P., Otgonbaatar, A., Ramamoorthy, A., Chua, E. H. Z., Harmston, N., Gruber, J., & Tolwinski, N. S. (2022) · Aging · doi:10.18632/aging.204347 · Cited by 20
“that this approach can be applied to human aging and age-related disease (14-18), and cycling expression can rejuvenate stem cells in vitro (19).”
BackgroundLiu, Z., Xue, J., Liu, C., Tang, J., Wu, S., Lin, J., Han, J., Zhang, Q., Wu, C., Huang, H., et al. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.373660 · Cited by 19
Pou3f1 orchestrates a gene regulatory network controlling contralateral retinogeniculate projections
Fries, M., Brown, T. W., Jolicoeur, C., Boulan, B., Boudreau‐Pinsonneault, C., Javed, A., Abram, P., & Cayouette, M. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112985 · Cited by 19
Exploring Epigenetic Modifications as Potential Biomarkers and Therapeutic Targets in Glaucoma
Tonti, E., dell’Omo, R., Filippelli, M., Spadea, L., Salati, C., Gagliano, C., Musa, M., & Zeppieri, M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25052822 · Cited by 20
Aging clocks, entropy, and the limits of age-reversalPreprint
Tarkhov, A. E., Denisov, K. A., & Fedichev, P. O. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.06.479300 · Cited by 19
Venkataraman, A., Kordic, I., Li, J., Zhang, N. Y., Bharadwaj, N. S., Fang, Z., Das, S., & Coskun, A. F. (2024) · npj Aging · doi:10.1038/s41514-024-00178-w · Cited by 21
Maf1 regulates axonal regeneration of retinal ganglion cells after injury
Chen, D., Sun, Y., Zhou, L.-Y., Yang, S., Hong, F.-Y., Liu, X., Sun, Z.-L., Huang, J., & Feng, D. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113948 · Cited by 18
Does senescence play a role in age-related macular degeneration?
Malek, G., Campisi, J., Kitazawa, K., Webster, C. M., Lakkaraju, A., & Skowronska‐Krawczyk, D. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109254 · Cited by 18
Tang, J., Liu, Z., Han, J., Xue, J., Liu, L., Lin, J., Wu, C., Zhang, Q., Wu, S., Liu, C., et al. (2022) · Antioxidants · doi:10.3390/antiox11102001 · Cited by 19
“Here, we mated Slc30a3fl/fl mice with mice expressing Cre recombinase under the control of the Vgat promoter (specifically active in retinal ACs) [45].”
BackgroundMethodAn evaluation of aging measures: from biomarkers to clocks
Wang, Q., Hou, T., Wang, Q., He, J., Wang, L., Si, J., & Chen, S. (2022) · Biogerontology · doi:10.1007/s10522-022-09997-4 · Cited by 18
“Based on this theory, he reversed vision loss in aged mice through restoring youthful DNA methylation pattern (Lu et al. 2020).”
BackgroundReece, A. S., & Hulse, G. K. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph192416721 · Cited by 19
“Moreover, an elegant study has proven not only that the epigenome controls the aging process but that reversion of epigenomic age can heal traumatic optic nerve injury, glaucoma and geriatric blindness as normally only seen in neonatal life [15].”
BackgroundResultThe Impact of Aging on the Function of Retinal Ganglion Cells
Prinz, J., Walter, P., Liu, H., & Prokosch, V. (2024) · Klinische Monatsblätter für Augenheilkunde · doi:10.1055/a-2239-0290 · Cited by 19
“Particularly, the ectopic expression of the Yamanaka transcription factors Oct4, Sox2, and Klf4 (OSK) was induced in mice using an adeno-associated virus (AAV) system [1].”
BackgroundMethodInfluentialRegeneration leads to global tissue rejuvenation in aging sexual planarians
Dai, X., Li, X., Tyshkovskiy, A., Zuckerman, C., Cheng, N., Lin, P., Paris, D., Qureshi, S., Kruglyak, L., Mao, X., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00847-9 · Cited by 22
“However, the aged hematopoietic stem cell system, which is critical to mammalian healthspan and lifespan, remains refractory to these interventions 2,17 and reprogramming reagents have to be delivered in a tissue-specific fashion 16 .”
Self-citationModeling Retinal Ganglion Cell Dysfunction in Optic Neuropathies
Porciatti, V., & Chou, T.-H. (2021) · Cells · doi:10.3390/cells10061398 · Cited by 18
“In a microbead mouse model of glaucoma resulting in substantial RGC loss and PERG loss, Lu et al, 2020 [40] intravitreally injected AAV vectors to”
BackgroundLi, C., Wu, S., Yong-quan, S., Peng, X.-Q., Gong, M., Du, H., Zhang, J., Teng, Z., Wang, N., & Liu, C. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101554 · Cited by 18
“31 By using multiple animal models of optic nerve and retinal injury, our study demonstrated that overexpression of Lhx2 improved RGC survival and promoted axon re-generation.”
Targeting multiple hallmarks of mammalian aging with combinations of interventions
Panchin, A. Y., Ogmen, A., Blagodatski, A. S., Egorova, A., Batin, M., & Glinin, T. S. (2024) · Aging · doi:10.18632/aging.206078 · Cited by 22
“No pronounced side effects were observed [132].”
Wang, Y., Zhu, L., Wei, L., et al. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.12.113 · Cited by 17
Li, R., Teng, Y., Guo, Y., Ren, J., Li, R., Luo, H., Chen, D., Feng, Z., Fu, Z., Zou, X., et al. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111868 · Cited by 19
Nurturing longevity through natural compounds: Where do we stand, and where do we go?
Todorova, M. N., Savova, M. S., Mihaylova, L. V., & Georgiev, M. I. (2024) · Food Frontiers · doi:10.1002/fft2.350 · Cited by 17
Premature aging in genetic diseases: what conclusions can be drawn for physiological aging
Milosic, F., Hengstschläger, M., & Osmanagic‐Myers, S. (2024) · Frontiers in Aging · doi:10.3389/fragi.2023.1327833 · Cited by 19
“The latter employs cyclic expression of OSK in retinal ganglions which was shown to promote axon regeneration (Lu et al., 2020).”
BackgroundEpigenetics in Alzheimer’s Disease: A Critical Overview
Villa, C., & Combi, R. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115970 · Cited by 18
“The first one consists in a partial reprogramming of cells focused on restoring them to a more youthful state by removing epigenetic marks using a combination of three transcription factors (Oct4, Sox2, and Klf4) [122].”
BackgroundManipulating cell fate through reprogramming: approaches and applications
Yagi, M., Horng, J. E., & Hochedlinger, K. (2024) · Development · doi:10.1242/dev.203090 · Cited by 17
Self-citationEnhanced efficiency of nonviral direct neuronal reprogramming on topographical patterns
Mattiassi, S., Rizwan, M., Grigsby, C. L., Zaw, A. M., Leong, K. W., & Yim, E. K. F. (2021) · Biomaterials Science · doi:10.1039/d1bm00400j · Cited by 17
RNA-Based Strategies for Cell Reprogramming toward Pluripotency
Bailly, A., Milhavet, O., & Lemaı̂tre, J.-M. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14020317 · Cited by 18
Li, W., Vanluchene, H., Raes, L., Peynshaert, K., Veys, L., Hernández, S. G., Lombaerde, E. D., Geest, B. G. D., Sanders, N. N., Moons, L., et al. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114027 · Cited by 19
Long Non-Coding RNAs in Retinal Ganglion Cell Apoptosis
Zhang, N., Cao, W., He, X., Xing, Y., & Yang, N. (2022) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-022-01210-x · Cited by 17
“Accumulating evidence indicates that genetic and genomic heterogeneities are closely associated with the pathogenesis, progression, and prognosis of traumatic optic neuropathy or other neurodegenerative diseases that lead to visual damage, such as aging, glaucoma, optic nerve transection, and diabetic retinopathy (Wig…”
BackgroundKoppel, S. J., Wilkins, H., Weidling, I. W., Wang, X., Menta, B. W., & Swerdlow, R. H. (2022) · Mitochondrion · doi:10.1016/j.mito.2022.12.004 · Cited by 15
Rizk, E., Madrid, A., Koueik, J., Sun, D., Stewart, K., Chen, D., Luo, S., Hong, F., Papale, L. A., Hariharan, N., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04463-4 · Cited by 16
Landsberger, T., Amit, I., & Alon, U. S. (2023) · GeroScience · doi:10.1007/s11357-023-00915-1 · Cited by 16
“…have shown that inflammatory conditions such as Covid-19 infection [62] and other stressors [63] can accelerate DNA methylation age, whereas lifestyle changes [64], plasma fraction treat-ment [65], cellular reprogramming [66], heterochronic parabiosis [36], or drug cocktail [67], can reduce it.”
Nissl Granules, Axonal Regeneration, and Regenerative Therapeutics: A Comprehensive Review
Bhati, M., Thakre, S., & Anjankar, A. P. (2023) · Cureus · doi:10.7759/cureus.47872 · Cited by 15
Relationships Between Regeneration, Wound Healing, and Cancer
Maggiore, G., & Zhu, H. (2023) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062822-123558 · Cited by 18
Chen, J., Yuan, X., Zhou, X., Xu, J., Zhang, X., & Duan, X. (2024) · Clinical Epigenetics · doi:10.1186/s13148-024-01723-w · Cited by 17
“Reprograming age-associated epigenetic modifications has been shown to reverse vision loss in glaucoma mouse models and in aged mice [49].”
BackgroundHalalopathy: Role of Entropy in the Aging Process
Alzeer, J. (2022) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2022.16.002205 · Cited by 16
Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogrammingPreprint
Chondronasiou, D., Gill, D., Mosteiro, L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.20.477063 · Cited by 16
A cellular identity crisis? Plasticity changes during aging and rejuvenationPreprint
Gorelov, R. A., & Hochedlinger, K. (2024) · Genes & Development · doi:10.1101/gad.351728.124 · Cited by 18
“This observation calls to mind the previously reported requirement for Tet-dependent demethylation during OKS-induced axon regeneration in mice (Lu et al. 2020).”
Self-citationGenetic and epigenetic regulators of retinal Müller glial cell reprogramming
Xiao, X., Liao, Z., & Zou, J. (2023) · Advances in Ophthalmology Practice and Research · doi:10.1016/j.aopr.2023.05.004 · Cited by 14
“Activation of Jak/Stat3 and Mapk/Erk pathways by growth factors or cytokines appears to be responsible for the changing of transcriptional patterns of RMGCs.”
BackgroundInfluentialAn effective pharmacological hydrogel induces optic nerve repair and improves visual function
Wang, L., Zhang, S., Han, Y., Tang, S., Li, J., Bu, L., Zhao, D., & Deng, H. (2023) · Science China Life Sciences · doi:10.1007/s11427-023-2394-3 · Cited by 15
“Genetic manipulation of RGCs induces their regeneration, suggesting that alterations in the RGC state may induce an intrinsic ability to regenerate, promoting axon repair (Lu et al., 2020; Nathan et al., 2020; Sun et al., 2011).”
InfluentialGlycogen synthase kinase 3 signaling in neural regeneration in vivo
Zhang, J., Yang, S., & Zhou, F. (2023) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjad075 · Cited by 18
“More importantly, the combined expression of three Yamanaka factors ( Oct4/Sox2/Klf4) in RGCs enhanced optic nerve regeneration in both young adult and aged mice ( Lu et al., 2020 ) .”
BackgroundTraversing the epigenetic landscape: DNA methylation from retina to brain in development and disease
Xu, C., Fu, X., Qin, H., & Yao, K. (2024) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2024.1499719 · Cited by 17
“Consistent with this, the largest DNA methylation study of HD to date documented AgeAccel effects in the blood of HD cases (Lu et al., 2020), further indicating that DNA methylation changes play a crucial role in HD progression (Ng et al., 2013).”
InfluentialCell reprogramming: methods, mechanisms and applications
Zhu, F., & Nie, G. (2025) · Cell Regeneration · doi:10.1186/s13619-025-00229-x · Cited by 26
“Partial reprogramming has been recently documented to restore vision in aged mice (Lu et al. 2020) or to extend the life span of mice of premature aging or physiological aging (Ocampo et al. 2016; Browder et al. 2022), demonstrating the therapeutic potential of partial reprogramming.”
Direct Reprogramming of Somatic Cells to Neurons: Pros and Cons of Chemical Approach
Mollinari, C., & Merlo, D. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03282-5 · Cited by 15
“1 3 ganglion cells and propose that epigenetic reprogramming, either by gene therapy or other means, may promote tissue repair and thus, may be a promising strategy for reverting age-related decline and aged-induced pathologies in humans [32].”
Background
Metadata
- Authors
- Lu, Y., Brommer, B., Tian, X., Krishnan, A., Meer, M., Wang, C., Vera, D. L., Zeng, Q., Yu, D., Bonkowski, M. S., Yang, J.-H., Zhou, S., Hoffmann, E. M., Karg, M. M., Schultz, M. B., Kane, A. E., Davidsohn, N., Korobkina, E., Chwalek, K., Rajman, L. A., Church, G. M., Hochedlinger, K., Gladyshev, V. N., Horvath, S., Levine, M. E., Gregory-Ksander, M. S., Ksander, B. R., He, Z., & Sinclair, D. A.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Massachusetts Eye and Ear Infirmary (US)
- Brigham and Women's Hospital (US)
- Massachusetts General Hospital (US)
- University of California, Los Angeles (US)
- Yale University (US)
- Corresponding author
- Sinclair, David A.
- ORCID
- Lu, Yuancheng
- Brommer, Benedikt
- Tian, Xiao
- Krishnan, Anitha
- Meer, Margarita
- Wang, Chen
- Vera, Daniel L.
- Zeng, Qiurui
- Yu, Doudou
- Bonkowski, Michael S.
- Yang, Jae-Hyun
- Zhou, Songlin
- Kane, Alice E.
- Davidsohn, Noah
- Korobkina, Ekaterina
- Chwalek, Karolina
- Rajman, Luis A.
- Church, George M.
- Hochedlinger, Konrad
- Gladyshev, Vadim N.
- Horvath, Steve
- Levine, Morgan E.
- Gregory-Ksander, Meredith S.
- Ksander, Bruce R.
- He, Zhigang
- Sinclair, David A.
- Venue
- Nature
- Published
- 2020-12-02
- Volume
- 588
- Issue
- 7836
- Pages
- 124-129
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7752134
- OpenAlex
- W3108896277
- Semantic Scholar
- aa9b261d01ca36831459cb82af4c0c4d460f7d14
- Cited by
- 820
- References
- 72
- Citations by year
- 2026: 125 · 2025: 132 · 2024: 154 · 2023: 172 · 2022: 140 · 2021: 89 · 2020: 7
- FWCI
- 33.16
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (R01AG067782, R37AG028730, R01AG019719, T32AG023480, K99AG068303, R01AG065403)
- National Eye Institute (R24EY028767, R21EY030276, R01EY021526, R01EY026939, P30EY012196, P30EY003790, R01EY025794)
- National Institute of General Medical Sciences (R37GM065204, R01GM065204)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54HD090255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Keywords
- cellular reprogramming, epigenetic aging, DNA methylation, Oct4, SOX2, KLF4, Yamanaka factors, retinal ganglion cells, axon regeneration, glaucoma, vision loss, TET1, TET2, demethylation, tissue regeneration, aged mice, epigenetic noise
- MeSH terms
- Kruppel-Like Factor 4, Dependovirus, Aging, Animals, Axons, Cell Survival, Disease Models, Animal, DNA-Binding Proteins, Eye, Female, Genetic Vectors, Glaucoma, Humans, Mice, Inbred C57BL, Nerve Regeneration, Proto-Oncogene Proteins, Retinal Ganglion Cells, Vision, Ocular, DNA Methylation, Optic Nerve Injuries, Epigenesis, Genetic, Cell Line, Tumor, Dioxygenases, Octamer Transcription Factor-3, Mice, Kruppel-Like Transcription Factors, SOXB1 Transcription Factors, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-09-28, under version 3 of the claim definition (prompt extract-v3).
A second model labelled each claim on 2026-09-28 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review